Flora Peyvandi/ X
Aug 3, 2026, 11:59
Flora Peyvandi: Roctavian Withdrawal Signals Adoption Challenges
Flora Peyvandi, Professor of Internal Medicine at the University of Milan, shared a post on X about a recent article she and her colleagues co-authored, published in Research and Practice in Thrombosis and Haemostasis (RPTH), adding:
“Roctavian Withdrawal: exploring the gap between innovation and healthcare system readiness in haemophilia A gene therapy – Research and Practice in Thrombosis and Haemostasis.”
Title: Roctavian Withdrawal: exploring the gap between innovation and healthcare system readiness in haemophilia A gene therapy
Authors: Matteo Nicola Dario Di Minno, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 3, 2026, 12:44Replaying the CSL Symposium on Gene Therapy Durability in Haemophilia – EAHAD
-
Aug 3, 2026, 12:43Shinta C: Takeda Marks a Milestone in Hemophilia Care
-
Aug 3, 2026, 12:37Deepak Kumar Dasmohapatra: Honored for Contributions to Transfusion Medicine and Immunohematology by the Governor of Chhattisgarh
-
Aug 3, 2026, 12:30Furkan Bahar: Thrombotic and Hemorrhagic Risk Profiles in Advanced Melanoma – Targeted vs Immune Combination Therapies
-
Aug 3, 2026, 12:28Tayyaba Iftikhar: When Platelets Talk to Cancer Cells
-
Aug 3, 2026, 12:19Heparin Beyond Anticoagulation in Sepsis – JTH
-
Aug 3, 2026, 12:14Yaqui Valenzuela: Hemophilia Care Evolves Beyond Factor Replacement
-
Aug 3, 2026, 12:12José Antonio García Erce: Which Oral Iron Therapy Should We Choose?
-
Aug 3, 2026, 11:49Thirunavukkarasu Angappan: Gene Therapy’s Slow Road to Routine Hemophilia Care